Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Decrease of erythrocyte receptors for the C3b fragment of complement in acquired immunodeficiency syndrome].

J H Cohen1, B Autran, M H Jouvin

  • 1Laboratoire d'Immunologie, Hôpital R. Debré, Reims.

Presse Medicale (Paris, France : 1983)
|April 23, 1988
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Alterations in responses to vaccines in older people].

Revue des maladies respiratoires·2019
Same author

PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM.

EBioMedicine·2017
Same author

Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

In vitro Activation of B-CLL Cells.

Leukemia & lymphoma·2016
Same author

[Biological follow-up of patients with HIV treated with anti-PD-1 or anti-PD-L1 for non-small cell bronchial carcinoma: A task group proposal].

Revue des maladies respiratoires·2016

The number of complement C3b receptors (CR1) on red blood cells (erythrocytes) is lower in symptomatic HIV/AIDS patients. This finding may help track disease progression in HIV-infected individuals.

Area of Science:

  • Immunology
  • Hematology
  • Virology

Context:

  • Human immunodeficiency virus (HIV) infection impacts the immune system.
  • Complement receptors play a role in immune responses.
  • Quantifying complement receptors on erythrocytes (CR1/E) can be a potential biomarker.

Purpose:

  • To measure the number of CR1 on erythrocytes in HIV-infected individuals and healthy controls.
  • To compare CR1/E levels between symptomatic HIV patients, asymptomatic carriers, and controls.
  • To evaluate the correlation between CR1/E levels and HIV disease severity.

Summary:

  • A new flow cytometry assay and radioimmunoassay were used to quantify CR1/E in HIV-infected individuals.
  • Symptomatic HIV/AIDS patients showed significantly decreased CR1/E counts compared to controls.

Related Experiment Videos

  • Asymptomatic HIV carriers had normal CR1/E levels, which correlated with clinical disease severity.

    • Impact:

    • Flow cytometry assessment of CR1/E can serve as a potential biomarker for HIV disease progression.
    • This method may be valuable for large-scale prospective clinical studies in HIV management.
    • Findings contribute to understanding the immunological changes associated with HIV infection.